Related Experiment Video
Updated: May 29, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Sphingolipids and hepatic steatosis.
Benjamin T Bikman1, Scott A Summers
1Program in Cardiovascular and Metabolic Disorders, Duke-NUS Graduate Medical School, Singapore.
Sphingolipid synthesis impacts fatty liver disease. Inhibiting sphingolipid pathways in rodents reduces liver triglycerides, offering potential therapeutic targets for metabolic disorders like fatty liver disease.
Area of Science:
- Biochemistry
- Metabolic diseases
- Lipid metabolism
Background:
- Fatty liver disease is linked to diabetes, cardiovascular disease, and cancer.
- Sphingolipid metabolism plays a role in hepatic triglyceride accumulation.
- Rodent studies show inhibiting sphingolipid synthesis resolves fatty liver.
Purpose of the Study:
- To investigate the relationship between sphingolipids and triglyceride synthesis.
- To identify potential therapeutic strategies for fatty liver disease.
Main Methods:
- Pharmacological inhibition of serine palmitoyltransferase.
- Pharmacological inhibition of glucosylceramide synthase.
- Genetic depletion of acid sphingomyelinase in rodent models.
Main Results:
- Significant reduction in hepatic triglyceride levels observed in rodent models.
- Demonstrated efficacy of sphingolipid synthesis inhibition in resolving hepatic steatosis.
- Highlighted the potential of targeting sphingolipid pathways for fatty liver treatment.
Conclusions:
- Sphingolipid metabolism is a critical factor in fatty liver development.
- Interventions targeting sphingolipid synthesis pathways show promise for treating fatty liver disease.
- Further research is needed to clarify mechanisms and human relevance.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatic Encephalopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Membrane Lipids
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...

